Cargando…
Novel two-chain structure utilizing KIRS2/DAP12 domain improves the safety and efficacy of CAR-T cells in adults with r/r B-ALL
Engineered T cells that express chimeric antigen receptors (CARs) have been a promising therapy for hematologic malignancies. The optimization of CAR structure using different signaling domains can alter a wide range of CAR-T cell properties, including anti-tumor activity, long-term persistence, and...
Autores principales: | Sun, Ming, Xu, Peipei, Wang, Enxiu, Zhou, Min, Xu, Tongpeng, Wang, Jing, Wang, Qian, Wang, Bo, Lu, Kaihua, Wang, Chen, Chen, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517091/ https://www.ncbi.nlm.nih.gov/pubmed/34703879 http://dx.doi.org/10.1016/j.omto.2021.08.014 |
Ejemplares similares
-
Durable remission related to CAR-T persistence in R/R B-ALL and long-term persistence potential of prime CAR-T
por: Shiqi, Li, et al.
Publicado: (2023) -
Debating DAP12
por: Van Epps, Heather L.
Publicado: (2005) -
615. Daptomycin (DAP) Synergy with β-Lactams in DAP-Resistant (DAP-R) E. faecium (Efm) Is Dependent On PBP5 Sequence and β-Lactam-binding Affinity
por: Khan, Ayesha, et al.
Publicado: (2019) -
The Dimerization Domain in DapE Enzymes Is required for Catalysis
por: Nocek, Boguslaw, et al.
Publicado: (2014) -
Balancing the Virulence and Antimicrobial Resistance in VISA DAP-R CA-MRSA Superbug
por: Salemi, Rossella, et al.
Publicado: (2022)